Gammaproteobacteria metabolize gemcitabine, inducing drug resistance via the bacterial enzyme cytidine deaminase (CDA), while CDA conversely directs 5- Fluorouracil (5-FU) to tumor cells, reducing its toxic effects and improving its pharmacokinetic properties. This evidence concerns the gene CDA and neoplasm.